Woodline Partners LP

Portfolio Companies 2026 for Woodline Partners LP: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Woodline Partners LP accounts for 7 tracked companies with verified cap-table data, 7 of which disclose round sizes totalling $2.1B. The median disclosed raise is $185M, and the largest is Mirador Therapeutics at $650M, ahead of Point Biopharma ($650M) and Tango Therapeutics ($225M).

The names that recur most often on these portfolio cap tables are Woodline Partners LP (7 companies), Farallon Capital Management (3 companies), Logos Capital (3 companies), Janus Henderson Investors (3 companies), Boxer Capital (2 companies), TCGX (2 companies). By latest disclosed round, the market skews Series B (4), IPO (1), Series A (1), Series D (1).

Best funded Woodline Partners LP companies

  1. Mirador Therapeutics — $650M (latest: Series B)
  2. Point Biopharma — $650M (latest: IPO)
  3. Tango Therapeutics — $225M (latest: Series A)
  4. LEXEO Therapeutics — $185M (latest: Series B)
  5. ShouTi — $158M (latest: Series B)
  6. Build A Rocket Boy — $110M (latest: Series D)
  7. Cedilla Therapeutics — $83M (latest: Series B)

Woodline Partners LP — related firms and companies (49)

Woodline Partners LP profile · All research reports